Global Prenatal Testing and Newborn Screening Service Market Research Report 2024
Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical
Publisher : MRA | Format : PDF
Global Prenatal Testing and Newborn Screening Service Market Research Report 2024
Prenatal testing and newborn screening are effective methods for early detection of genetic metabolic diseases.
According to MRAResearch’s new survey, global Prenatal Testing and Newborn Screening Service market is projected to reach US$ 13720 million in 2033, increasing from US$ 5483.4 million in 2022, with the CAGR of 14.0% during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Prenatal Testing and Newborn Screening Service market research.
Rapidly growing global population, rising adoption rate of obstetric testing equipment in clinics, rapid development of modern healthcare, and continuous regulation across the healthcare industry are the key factors driving the growth of prenatal testing and newborn screening services market revenue.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Prenatal Testing and Newborn Screening Service market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
PerkinElmer
Natera
Invitae
Centogene
Illumina
Natus Medical
Sequenom
Cradle Genomics
Hoffmann-La Roche
Quest Diagnostics
Baebies
Ravgen
Eurofins Scientific
BGI Genomics
Shanghai Biotecan Pharmaceuticals Corporation
Annaroad Gene
Guangzhou Darui Biotechnology
Beijing Berry Genomics
Segment by Type
Intrusive
Non-Invasive
Hospital
Diagnostic Center
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Prenatal Testing and Newborn Screening Service report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source
According to MRAResearch’s new survey, global Prenatal Testing and Newborn Screening Service market is projected to reach US$ 13720 million in 2033, increasing from US$ 5483.4 million in 2022, with the CAGR of 14.0% during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Prenatal Testing and Newborn Screening Service market research.
Rapidly growing global population, rising adoption rate of obstetric testing equipment in clinics, rapid development of modern healthcare, and continuous regulation across the healthcare industry are the key factors driving the growth of prenatal testing and newborn screening services market revenue.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Prenatal Testing and Newborn Screening Service market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
PerkinElmer
Natera
Invitae
Centogene
Illumina
Natus Medical
Sequenom
Cradle Genomics
Hoffmann-La Roche
Quest Diagnostics
Baebies
Ravgen
Eurofins Scientific
BGI Genomics
Shanghai Biotecan Pharmaceuticals Corporation
Annaroad Gene
Guangzhou Darui Biotechnology
Beijing Berry Genomics
Segment by Type
Intrusive
Non-Invasive
Segment by Application
Hospital
Diagnostic Center
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Prenatal Testing and Newborn Screening Service report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source